John CPA - T2 Biosystms Chief Officer
TTOODelisted Stock | USD 0.18 0.05 21.74% |
Insider
John CPA is Chief Officer of T2 Biosystms
Age | 67 |
Phone | 781 761 4646 |
Web | https://www.t2biosystems.com |
T2 Biosystms Management Efficiency
The company has return on total asset (ROA) of (0.9046) % which means that it has lost $0.9046 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (6.2214) %, meaning that it created substantial loss on money invested by shareholders. T2 Biosystms' management efficiency ratios could be used to measure how well T2 Biosystms manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Emily Hubbard | iSpecimen | N/A | |
Alexander MD | Illumina | 47 | |
Carissa Rollins | Illumina | 54 | |
BBus CA | Intelligent Bio Solutions | 60 | |
Sandy Pound | Thermo Fisher Scientific | N/A | |
Scott Ericksen | Illumina | 52 | |
Jill Mullan | iSpecimen | 59 | |
Tracy Curley | iSpecimen | 62 | |
David MD | iSpecimen | N/A | |
Kevin Kempskie | Waters | N/A | |
C Harris | Thermo Fisher Scientific | 64 | |
Alex Arzeno | Intelligent Bio Solutions | N/A | |
Ruby Chandy | Thermo Fisher Scientific | 58 | |
Syed Jafry | Thermo Fisher Scientific | 56 | |
Jianqing Bennett | Waters | 55 | |
Dawn Michelle | iSpecimen | N/A | |
John Ballbach | Waters | 60 | |
Kevin Pegels | Illumina | 57 | |
Belinda Hyde | Waters | 53 | |
Dan Welch | Waters | 58 | |
JoseCarlos GutierrezRamos | Danaher | 63 |
Management Performance
Return On Equity | -6.22 | ||||
Return On Asset | -0.9 |
T2 Biosystms Leadership Team
Elected by the shareholders, the T2 Biosystms' board of directors comprises two types of representatives: T2 Biosystms inside directors who are chosen from within the company, and outside directors, selected externally and held independent of TTOO. The board's role is to monitor T2 Biosystms' management team and ensure that shareholders' interests are well served. T2 Biosystms' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, T2 Biosystms' outside directors are responsible for providing unbiased perspectives on the board's policies.
Roger Smith, Senior Development | ||
Aparna MD, Chief Board | ||
Kelley Morgan, Chief Officer | ||
BSc III, CEO President | ||
Michael Esq, Sr Counsel | ||
Brett Giffin, Chief Officer | ||
Alec Barclay, Senior Vice President - Operations | ||
John CPA, Chief Officer |
TTOO Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is T2 Biosystms a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -6.22 | ||||
Return On Asset | -0.9 | ||||
Operating Margin | (4.91) % | ||||
Current Valuation | 21.91 M | ||||
Shares Outstanding | 21.04 M | ||||
Shares Owned By Insiders | 10.17 % | ||||
Shares Owned By Institutions | 73.51 % | ||||
Number Of Shares Shorted | 826.91 K | ||||
Price To Earning | (2.04) X | ||||
Price To Book | 14.50 X |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in T2 Biosystms. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Consideration for investing in TTOO Pink Sheet
If you are still planning to invest in T2 Biosystms check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the T2 Biosystms' history and understand the potential risks before investing.
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |